BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15468547)

  • 1. [Aprotinin in the correction of the hemodynamic syndrome of systemic inflammatory response in surgeries with extracorporeal circulation].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG; Kim SF
    Anesteziol Reanimatol; 2004; (4):15-9. PubMed ID: 15468547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastase release following myocardial ischemia during extracorporeal circulation (ECC) -- marker of ongoing systemic inflammation?
    Boeken U; Feindt P; Schulte HD; Gams E
    Thorac Cardiovasc Surg; 2002 Jun; 50(3):136-40. PubMed ID: 12077684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.
    Harmon DC; Ghori KG; Eustace NP; O'Callaghan SJ; O'Donnell AP; Shorten GD
    Can J Anaesth; 2004 Dec; 51(10):1002-9. PubMed ID: 15574551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG
    Vestn Khir Im I I Grek; 2005; 164(6):69-73. PubMed ID: 16792320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
    Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of aminocapronic acid and small-dose trasilol on blood loss after cardiac surgery with extracorporeal circulation].
    Morozov IuA; Charnaia MA; Gladysheva VG
    Anesteziol Reanimatol; 2005; (4):58-60. PubMed ID: 16206590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of aprotinin on blood loss reduction after extracorporeal circulation].
    Ueyama K; Kawasuji M; Sakakibara N; Tedoriya T; Takahashi M; Watanabe Y
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Oct; 41(10):2093-9. PubMed ID: 7693833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin reduces cardiac troponin I release and inhibits apoptosis of polymorphonuclear cells during off-pump coronary artery bypass surgery.
    Bert C; De Buck F; Sergeant P; Van Hemelrijck J; Kasran A; Van Duppen V; Ceuppens J; Meyns B; Delforge M; Wouters P
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):16-22. PubMed ID: 18249325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of high doses of aprotinin on intra- and postoperative blood loss in surgery with artificial circulation].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1995; (2):91-3. PubMed ID: 7544074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients?
    Schmartz D; Tabardel Y; Preiser JC; Barvais L; d'Hollander A; Duchateau J; Vincent JL
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):184-90. PubMed ID: 12539003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there really a clinical benefit of using minimized extracorporeal circulation for coronary artery bypass grafting?
    Schöttler J; Lutter G; Böning A; Soltau D; Bein B; Caliebe D; Haake N; Schoeneich F; Cremer J
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):65-70. PubMed ID: 18278679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
    Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A
    Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.